<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">

  <url>
    <loc>https://www.basisreport.com/news/eroc-erock-s-losses-deepen-as-institutions-pile-in</loc>
    <lastmod>2026-09-09T10:21:14.838Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T10:21:09.640Z</news:publication_date>
      <news:title>ERock&apos;s Losses Deepen as Institutions Pile In</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/payp-paypay-shares-rise-6-3-as-analyst-target-sits-at-24-87</loc>
    <lastmod>2026-09-09T10:11:10.083Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T10:11:04.398Z</news:publication_date>
      <news:title>PayPay Shares Rise 6.3% as Analyst Target Sits at $24.87</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/nams-cso-sold-before-phase-3-readout</loc>
    <lastmod>2026-09-09T10:15:03.880Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T08:28:24.456Z</news:publication_date>
      <news:title>NAMS CSO Sold $3.4M Before Phase 3 Data Readout</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/himx-himax-s-30-target-vs-14-reality-who-s-right</loc>
    <lastmod>2026-09-09T08:12:27.348Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T08:11:56.464Z</news:publication_date>
      <news:title>Himax&apos;s $30 Target vs. $14 Reality: Who&apos;s Right?</news:title>
    </news:news>
  </url>
</urlset>